Nothing Has Changed About the Healing Power of MDMA-Assisted Therapy
So after years of hype and hope, the FDA did not approve MDMA Assisted Therapy for the treatment of PTSD at this time. This is a tectonic shift in the entire field of psychedelic therapies. Here are some of my reflections on this historic decision.
“How MDMA Therapy saved a veteran” with Jonathan Lubecky – MDMA THERAPY PODCAST #23
After several suicide attempts, a US veteran found MDMA Assisted Therapy, which he claims not only saved his life but also cured him of PTSD. Listen to Jonathan’s remarkable story.
How Power Trip became its own power trip
A report on the state of the MDMA Therapy orchard
“What happened at the FDA Expert Panel meeting regarding MDMA Therapy?” with Matthew Baggott – MDMA THERAPY PODCAST #22
Dr. Matthew Baggot (a neuroscientist and expert on both the neurophysiology and phenomenology of MDMA and on the FDA drug approval process) shares a number of very interesting, unique, and nuanced insights about the FDA Expert Panel meeting regarding MDMA-Assisted Therapy.
FDA Psychopharmacologic Drug Advisory Committee rejects use of MDMA-Assisted Therapy for PTSD
In a stunning decision, an FDA-appointed advisory committee, comprised of 11 independent experts, rejected MDMA-Assisted Therapy as a treatment for PTSD, voting that the evidence for both its effectiveness and safety is insufficient.
Psychedelic Alpha on June 4th FDA Advisory Meeting
June 4th is fast approaching, with a group of experts scheduled to meet to advise the FDA on whether to approve MDMA-assisted therapy for the treatment of PTSD.
June 4 2024 is an important date for MDMA-Assisted Therapy
The FDA is currently in the final stages of the MDMA-Assisted Therapy approval process, with the decision expected in August 2024. The next stage in the approval process is the meeting of the FDA Advisory Committee on June 4 to review Lykos Therapeutics’ application.
“MDMA Therapy Training at TheraPsil” with Yasmeen deRosenroll – MDMA THERAPY PODCAST #21
TheraPsil is a Canadian West Coast non-profit, best known for their pioneering work with Psilocybin-Assisted Therapy for end-of-life anxiety, as well as their incredible national advocacy efforts. Recently, TheraPsil added MDMA-Assisted Therapy Training to their roster of offerings. Join us for a conversation with Yasmeen de Rosenroll, TheraPsil’s Director of Training and Operations.
“Rachel Nuwer: History of MDMA″ – MDMA THERAPY PODCAST #20
Rachel Nuwer is a science journalist. Her new book “I Feel Love” is to-date the most comprehensive account of the history of MDMA. Rachel paints numerous stories about various colorful people related to the history of MDMA.
“Pamela Kryskow: And the Psychedelic Re-emergence″ – MDMA THERAPY PODCAST #19
Dr. Pamela Kryskow is a powerful force reshaping the Canadian psychedelic scene. In this episode, she talks about various psychedelic initiatives she helped co-create, including a progressive non-profit Roots to Thrive Psychedelic Assisted Therapy, the Psychedelic Association of Canada, the first Canadian post-graduate certificate in psychedelic therapies, and the largest-ever psilocybin microdosing study with over 33,000 participants.
